{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T17:35:58Z","timestamp":1784136958477,"version":"3.55.0"},"reference-count":25,"publisher":"Bentham Science Publishers Ltd.","issue":"12","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["EMIDDT"],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:sec>\n<jats:title>Background &amp; Aims:<\/jats:title>\n<jats:p>Non-alcoholic fatty liver disease (NAFLD) is an emerging epidemic;\nit is a negative diagnosis that depends mainly on the presence of hepatic steatosis with or\nwithout inflammation after the exclusion of other chronic liver diseases and excess alcohol intake.\nHowever, the new definition of MAFLD is a shift towards a diagnosis of inclusion based on\nthe presence of metabolic dysfunction, regardless of alcohol consumption or other concomitant\nliver diseases. Given the growing relevance of the disease, data on hepatologists' views and understanding\nof NAFLD are limited, we aimed to determine hepatologists' awareness and expertise\nof NAFLD screening, diagnosis, and therapeutic options as well as the influence of changing\nthe NAFLD name to MAFLD on awareness of the fatty liver disease (FLD).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>Most of the hepatologists agreed that NAFLD can cause serious hepatic illness and\nmay be linked to metabolic risk factors, necessitating a multidisciplinary approach to treatment.\nHepatologists have a poor understanding of NAFLD care. The shift in terminology from NAFLD\nto MAFLD will be more known to hepatologists, and it may offer better awareness of FLD.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>A multicenter online questionnaire of 655 hepatologists was carried out, giving a sample\nof 207 respondents. A survey composed of 36 questions was used to assess the level of hepatologists'\nawareness and practices in the screening, diagnosis, and management of\nNAFLD\/MAFLD, as well as their familiarity with the nomenclature change from NAFLD to\nMAFLD.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>A total of 207 hepatologists were included, of which 107 (51.4%) were males, with a\nmean age was 36.4 years. 50.2% (n = 104) of the hepatologists were oriented with NAFLD. Only\n41 (19.8%) realized that NAFLD may frequently result in severe hepatic disease. NAFLD is rarely\nscreened by the majority of the participating hepatologists (118, 57%), and (135, 65.2%) of\nthem use liver biopsy for diagnosis of NAFLD. In (104, 50.2%) hepatologists, changing the nomenclature\nof NAFLD was relatively familiar. Furthermore, 71.9% of hepatologists thought that\nthe new nomenclature offers a better awareness of FLD.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>A small percentage of hepatologists agreed that NAFLD can cause serious hepatic\nillness and may be linked to metabolic risk factors, and around half of them realize that NAFLD\nnecessitates a multidisciplinary approach to treatment. Hepatologists have a poor understanding\nof NAFLD care. The shift in terminology from NAFLD to MAFLD will be more known to hepatologists,\nand it may offer better awareness of FLD.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871530323666221028154159","type":"journal-article","created":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T19:18:15Z","timestamp":1666984695000},"page":"1445-1453","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Hepatologists\u2019 Awareness and Knowledge of NAFLD and the Familiarity\nwith Renaming NAFLD to MAFLD"],"prefix":"10.2174","volume":"24","author":[{"given":"Shereen Abdel","family":"Alem","sequence":"first","affiliation":[{"name":"Department of Endemic Medicine and Hepatology, Faculty of Medicine, Cairo University, Cairo, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasser","family":"Fouad","sequence":"additional","affiliation":[{"name":"Department\nof Gastroenterology, Hepatology and Endemic Medicine, Faculty of Medicine, Minia University, Minia, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"AbdAllah","sequence":"additional","affiliation":[{"name":"Medical Research Division, National Research Centre, Giza, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Attia","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology\nand Endemic Medicine, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inas","family":"Kamal","sequence":"additional","affiliation":[{"name":"Department\nof Gastroenterology, Hepatology and Endemic Medicine, Faculty of Medicine, Minia University, Minia, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebada","family":"Said","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology,\nHepatology and Endemic Medicine, Faculty of Medicine, Benha University, Benha, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Gomaa","sequence":"additional","affiliation":[{"name":"Department of Tropical\nMedicine, Faculty of Medicine, Fayoum University, Fayoum, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherief M.","family":"Abd-Elsalam","sequence":"additional","affiliation":[{"name":"Department of Tropical Medicine, Faculty of\nMedicine, Tanta University, Tanta, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmine","family":"Gaber","sequence":"additional","affiliation":[{"name":"Department of Endemic Medicine and Hepatology, Faculty of Medicine, Cairo University, Cairo, Egypt."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"8263","DOI":"10.3748\/wjg.v23.i47.8263","volume":"23","author":"Perumpail B.J.","year":"2017","unstructured":"Perumpail B.J.; Khan M.A.; Yoo E.R.; Cholankeril G.; Kim D.; Ahmed A.; Clinical epidemiology and disease burden of nonalcoholic fatty liver disease. World J Gastroenterol  2017,23(47),8263-8276","journal-title":"World J Gastroenterol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41575-020-0315-7","volume":"17","author":"Lazarus J.V.","year":"2020","unstructured":"Lazarus J.V.; Colombo M.; Cortez P.H.; Huang T.T.K.; Miller V.; Ninburg M.; Schattenberg J.M.; Seim L.; Wong V.W.S.; Zelber S.S.; NAFLD \u2014 sounding the alarm on a silent epidemic. Nat Rev Gastroenterol Hepatol  2020,17(7),377-379","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","volume":"158","author":"Eslam M.","year":"2020","unstructured":"Eslam M.; Sanyal A.J.; George J.; Sanyal A.; Neuschwander T.B.; Tiribelli C.; Kleiner D.E.; Brunt E.; Bugianesi E.; Yki J.H.; Gr\u00f8nb\u00e6k H.; Cortez P.H.; George J.; Fan J.; Valenti L.; Abdelmalek M.; Romero G.M.; Rinella M.; Arrese M.; Eslam M.; Bedossa P.; Newsome P.N.; Anstee Q.M.; Jalan R.; Bataller R.; Loomba R.; Sookoian S.; Sarin S.K.; Harrison S.; Kawaguchi T.; Wong V.W.S.; Ratziu V.; Yilmaz Y.; Younossi Z.; International consensus panel. MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology  2020,158(7),1999-2014.e1","journal-title":"Gastroenterology"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Younossi Z.","year":"2018","unstructured":"Younossi Z.; Anstee Q.M.; Marietti M.; Hardy T.; Henry L.; Eslam M.; George J.; Bugianesi E.; Global burden of NAFLD and NASH: Trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol  2018,15(1),11-20","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S2468-1253(19)30342-5","volume":"5","author":"Sarin S.K.","year":"2020","unstructured":"Sarin S.K.; Kumar M.; Eslam M.; George J.; Al Mahtab M.; Akbar S.M.F.; Jia J.; Tian Q.; Aggarwal R.; Muljono D.H.; Omata M.; Ooka Y.; Han K.H.; Lee H.W.; Jafri W.; Butt A.S.; Chong C.H.; Lim S.G.; Pwu R.F.; Chen D.S.; Liver diseases in the Asia-Pacific region: A lancet gastroenterology and hepatology commission. Lancet Gastroenterol Hepatol  2020,5(2),167-228","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","volume":"62","author":"Byrne C.D.","year":"2015","unstructured":"Byrne C.D.; Targher G.; NAFLD: A multisystem disease. J Hepatol  2015,62(Suppl.),S47-S64","journal-title":"J Hepatol"},{"key":"ref=7","first-page":"2101","volume":"50","author":"Jepsen P.","year":"2003","unstructured":"Jepsen P.; Vilstrup H.; Mellemkjaer L.; Thulstrup A.M.; Olsen J.H.; Baron J.A.; S\u00f8rensen H.T.; Prognosis of patients with a diagnosis of fatty liver-a registry-based cohort study. Hepatogastroenterology  2003,50(54),2101-2104","journal-title":"Hepatogastroenterology"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1097\/00004836-200304000-00015","volume":"36","author":"S\u00f8rensen H.T.","year":"2003","unstructured":"S\u00f8rensen H.T.; Mellemkj\u00e6r L.; Jepsen P.; Thulstrup A.M.; Baron J.; Olsen J.H.; Vilstrup H.; Risk of cancer in patients hospitalized with fatty liver: A Danish cohort study. J Clin Gastroenterol  2003,36(4),356-359","journal-title":"J Clin Gastroenterol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1111\/jgh.15320","volume":"36","author":"Liu D.","year":"2021","unstructured":"Liu D.; Shen Y.; Zhang R.; Xun J.; Wang J.; Liu L.; Steinhart C.; Chen J.; Lu H.; Prevalence and risk factors of metabolic associated fatty liver disease among people living with HIV in China. J Gastroenterol Hepatol  2021,36(6),1670-1678","journal-title":"J Gastroenterol Hepatol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"Eslam M.","year":"2020","unstructured":"Eslam M.; Newsome P.N.; Sarin S.K.; Anstee Q.M.; Targher G.; Romero G.M.; Zelber S.S.; Wai S.W.V.; Dufour J.F.; Schattenberg J.M.; Kawaguchi T.; Arrese M.; Valenti L.; Shiha G.; Tiribelli C.; Yki J.H.; Fan J.G.; Gr\u00f8nb\u00e6k H.; Yilmaz Y.; Cortez P.H.; Oliveira C.P.; Bedossa P.; Adams L.A.; Zheng M.H.; Fouad Y.; Chan W.K.; Mendez S.N.; Ahn S.H.; Castera L.; Bugianesi E.; Ratziu V.; George J.; A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J Hepatol  2020,73(1),202-209","journal-title":"J Hepatol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1111\/j.1440-1746.2009.06026.x","volume":"24","author":"de Silva H.J.","year":"2009","unstructured":"de Silva H.J.; Dassanayake A.S.; Non-alcoholic fatty liver disease: Confronting the global epidemic requires better awareness. J Gastroenterol Hepatol  2009,24(11),1705-1707","journal-title":"J Gastroenterol Hepatol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","volume":"70","author":"Younossi Z.M.","year":"2019","unstructured":"Younossi Z.M.; Non-alcoholic fatty liver disease \u2013 A global public health perspective. J Hepatol  2019,70(3),531-544","journal-title":"J Hepatol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"Chalasani N.","year":"2018","unstructured":"Chalasani N.; Younossi Z.; Lavine J.E.; Charlton M.; Cusi K.; Rinella M.; Harrison S.A.; Brunt E.M.; Sanyal A.J.; The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the study of liver diseases. Hepatology  2018,67(1),328-357","journal-title":"Hepatology"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.dld.2017.01.147","volume":"49","author":"Lonardo A.","year":"2017","unstructured":"Lonardo A.; Nascimbeni F.; Targher G.; Bernardi M.; Bonino F.; Bugianesi E.; Casini A.; Gastaldelli A.; Marchesini G.; Marra F.; Miele L.; Morisco F.; Petta S.; Piscaglia F.; Svegliati-Baroni G.; Valenti L.; Bellentani S.; AISF position paper on Nonalcoholic Fatty Liver Disease (NAFLD): Updates and future directions. Dig Liver Dis  2017,49(5),471-483","journal-title":"Dig Liver Dis"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1007\/s10620-016-4044-2","volume":"61","author":"Corey K.E.","year":"2016","unstructured":"Corey K.E.; Klebanoff M.J.; Tramontano A.C.; Chung R.T.; Hur C.; Screening for nonalcoholic steatohepatitis in individuals with type 2 diabetes: A cost-effectiveness analysis. Dig Dis Sci  2016,61(7),2108-2117","journal-title":"Dig Dis Sci"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1445-5994.2012.02848.x","volume":"43","author":"Bergqvist C.J.","year":"2013","unstructured":"Bergqvist C.J.; Skoien R.; Horsfall L.; Clouston A.D.; Jonsson J.R.; Powell E.E.; Awareness and opinions of non-alcoholic fatty liver disease by hospital specialists. Intern Med J  2013,43(3),247-253","journal-title":"Intern Med J"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.jhep.2012.03.019","volume":"57","author":"Ratziu V.","year":"2012","unstructured":"Ratziu V.; Cadranel J.F.; Serfaty L.; Denis J.; Renou C.; Delassalle P.; Bernhardt C.; Perlemuter G.; A survey of patterns of practice and perception of NAFLD in a large sample of practicing gastroenterologists in France. J Hepatol  2012,57(2),376-383","journal-title":"J Hepatol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","volume":"64","year":"2016","unstructured":"European Association for the Study of Liver. EASL\u2013EASD\u2013EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease. J Hepatol  2016,64(6),1388-1402","journal-title":"J Hepatol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.dld.2006.03.021","volume":"38","author":"Palmentieri B.","year":"2006","unstructured":"Palmentieri B.; Desio I.; Lamura V.; Masarone M.; Vecchione R.; Bruno S.; Torella R.; Persico M.; The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis. Dig Liver Dis  2006,38(7),485-489","journal-title":"Dig Liver Dis"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.jhep.2009.09.001","volume":"51","author":"Dasarathy S.","year":"2009","unstructured":"Dasarathy S.; Dasarathy J.; Khiyami A.; Joseph R.; Lopez R.; McCullough A.J.; Validity of real time ultrasound in the diagnosis of hepatic steatosis: A prospective study. J Hepatol  2009,51(6),1061-1067","journal-title":"J Hepatol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jhep.2015.04.006","volume":"63","year":"2015","unstructured":"EASL-ALEH clinical practice guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol  2015,63(1),237-264","journal-title":"J Hepatol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"233","DOI":"10.4254\/wjh.v13.i2.233","volume":"13","author":"Wessels D.H.","year":"2021","unstructured":"Wessels D.H.; Rosenberg Z.; Awareness of non-alcoholic steatohepatitis and treatment guidelines: What are physicians telling us? World J Hepatol  2021,13(2),233-241","journal-title":"World J Hepatol"},{"key":"ref=23","first-page":"389","volume":"17","author":"Grattagliano I.","year":"2008","unstructured":"Grattagliano I.; D\u2019Ambrosio G.; Palmieri V.O.; Moschetta A.; Palasciano G.; Portincasa P.; Improving nonalcoholic fatty liver disease management by general practitioners: A critical evaluation and impact of an educational training program. J Gastrointestin Liver Dis  2008,17(4),389-394","journal-title":"J Gastrointestin Liver Dis"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11901-016-0295-9","volume":"15","author":"VanWagner L.B.","year":"2016","unstructured":"VanWagner L.B.; Rinella M.E.; Extrahepatic manifestations of nonalcoholic fatty liver disease. Curr Hepatol Rep  2016,15(2),75-85","journal-title":"Curr Hepatol Rep"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.jhep.2008.06.018","volume":"49","author":"Ong J.P.","year":"2008","unstructured":"Ong J.P.; Pitts A.; Younossi Z.M.; Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease. J Hepatol  2008,49(4),608-612","journal-title":"J Hepatol"}],"container-title":["Endocrine, Metabolic &amp; Immune Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871530323666221028154159","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/210456\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871530323666221028154159","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T06:25:56Z","timestamp":1727936756000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/210456\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871530323666221028154159","relation":{},"ISSN":["1871-5303"],"issn-type":[{"value":"1871-5303","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-03-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-08","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}